Richard M. Weinshilboum MD

Dr. Weinshilboum received BA and MD degrees from the University of Kansas, followed by residency training in Internal Medicine at the Massachusetts General Hospital in Boston. He was also a Pharmacology Research Associate at the National Institutes of Health (NIH) in the NIMH laboratory of Nobel Laureate Dr. Julius Axelrod. Dr. Weinshilboum’s research has focused on pharmacogenomics, with over 500 published manuscripts on that topic. In recent decades he has applied genome-wide genomics and other “omics” techniques to study variation in drug response for a variety of diseases ranging from breast cancer and childhood leukemia to depression and alcohol use disorder. Dr. Weinshilboum has been the recipient of many awards including appointment as an Established Investigator of the American Heart Association, a Burroughs Wellcome Scholar Award in Clinical Pharmacology, the Oscar B. Hunter Award for Experimental Therapeutics of the American Society for Clinical Pharmacology and Therapeutics, the ASPET Harry Gold Award in Clinical Pharmacology, the Edvard Poulsson Award from the Norwegian Pharmacology Society and an honorary Doctor of Science degree from the University of Kansas. Dr. Weinshilboum has served as a member of the National Advisory Councils for two US NIH Institutes, the National Institute for General Medical Sciences (NIGMS)—the NIH Institute where Pharmacology is based--and the National Human Genome Research Institute (NHGRI)—the NIH Institute that sponsored the Human Genome Project.